Tibet Weixinkang Medicine Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 350.38 million compared to CNY 315.28 million a year ago. Revenue was CNY 350.38 million compared to CNY 315.28 million a year ago.

Net income was CNY 60.25 million compared to CNY 38.91 million a year ago. Basic earnings per share from continuing operations was CNY 0.14 compared to CNY 0.09 a year ago. Diluted earnings per share from continuing operations was CNY 0.14 compared to CNY 0.09 a year ago.